Trial intelligence / Profile preview

AKM Lab-01 in Overweight and Obesity

NCT07331974Recruiting

Sponsor
MoonBio
Start
Jun 2026
Primary completion
Mar 2027
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, double-blind trial in obesity comparing Probiotics (AKM Lab-01) with Placebo (2 arms). Primary endpoints: Body Mass Index at Day 90 and Body Weight at Day 90. Started Jun 2026; status: recruiting.

02

Drugs

AKM Lab-01
03

Conditions

obesity

Beyond the preview

Go deeper on NCT07331974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07331974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call